Higher dose but not low dose proton pump inhibitors are associated with increased risk of subsequent hip fractures after first hip fracture: A nationwide observational cohort study

AIM: To examine the association of proton pump inhibitor (PPI) use with subsequent hip fracture incidence in hip fracture patients, accounting for gender, age, PPI doses, PPI initiation before or after first fracture, and year from first fracture in which the first subsequent fracture occurred. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Brozek, Wolfgang, Reichardt, Berthold, Zwerina, Jochen, Dimai, Hans Peter, Klaushofer, Klaus, Zwettler, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451165/
https://www.ncbi.nlm.nih.gov/pubmed/30993153
http://dx.doi.org/10.1016/j.bonr.2019.100204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451165/
https://www.ncbi.nlm.nih.gov/pubmed/30993153
http://dx.doi.org/10.1016/j.bonr.2019.100204

Ejemplares similares